caLogo

One of NOTE’s Swedish plants has received a first order of SEK 25 million from a Swedish customer within the medtech segment. Delivery is scheduled for 2020.

NOTE, together with the customer, has for about two years carried out a comprehensive development project which is now entering the next phase as the customer has ordered units for validation and evaluation. If this works out well, there are good opportunities to grow further with the customer in the future.

“Our strategic focus on the medtech segment is developing very strongly. So far, we have grown this segment with more than 55% in 2019. This is yet another proof that our service offering is a very good match to the requirements of demanding medtech companies,” says Johannes Lind-Widestam, NOTE’s CEO and President.

Submit to FacebookSubmit to Google PlusSubmit to TwitterSubmit to LinkedInPrint Article